2021 annual financial data
PTC Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -46.66%.
Operating income was -374,443,000 USD and net income was -523,901,000 USD.
Operating cash flow was -251,332,000 USD.
Get free PTC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 538,593,000 USD
- Operating income
- -374,443,000 USD
- Net income
- -523,901,000 USD
- Operating cash flow
- -251,332,000 USD